TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Karo Pharma Sverige AB
Closing information (x1000 DKK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover |
201,360
|
169,522
|
210,153 |
Financial expenses |
251
|
93
|
110 |
Earnings before taxes |
-11,867
|
-9,222
|
-760 |
EBITDA |
-11,412
|
-60,967
|
5,996 |
Total assets |
215,466
|
221,434
|
112,860 |
Current assets |
214,940
|
220,603
|
78,778 |
Current liabilities |
58,757
|
49,335
|
80,829 |
Equity capital |
156,709
|
172,020
|
31,955 |
- share capital |
114
|
116
|
112 |
Employees (average) |
129
|
93
|
40 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency |
72.7%
|
77.7%
|
28.3% |
Turnover per employee |
1,561
|
1,823
|
5,254 |
Profit as a percentage of turnover |
-5.9%
|
-5.4%
|
-0.4% |
Return on assets (ROA) |
-5.4%
|
-4.1%
|
-0.6% |
Current ratio |
365.8%
|
447.2%
|
97.5% |
Return on equity (ROE) |
-7.6%
|
-5.4%
|
-2.4% |
Change turnover |
35,047
|
-48,038
|
771 |
Change turnover % |
21%
|
-22%
|
0% |
Chg. No. of employees |
36
|
53
|
11 |
Chg. No. of employees % |
39%
|
133%
|
38% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.